CTH was specifically up-regulated in IDH1-mutant astrocytomas to sustain de novo GSH production under cysteine restriction, and CTH inhibition with brain-penetrant propargylglycine impaired tumor growth in vivo [16]. The gene discussed is CTH; the disease is astrocytoma (excluding glioblastoma).